Journal Article Comment Epublish
PubMed: 40486201 DOI: 10.3389/fmed.2025.1558264
Commentary: Evaluation of post-COVID mortality risk in cases classified as severe acute respiratory syndrome in Brazil: a longitudinal study for medium and long term.
Front Med (Lausanne) 12:1558264
Authors: Rubens C Costa-Filho, José Paulo G Leite, Marco Aurélio Horta, Felipe Gomes Naveca, Felipe Saddy, Hugo C Castro de Faria Neto
Affiliations
- Laboratory of Immunopharmacology, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil. Estácio Medical School - IDOMED, Rio de Janeiro, Brazil.
- Laboratory of Comparative and Environmental Virology, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil.
- Biosafety Level 3 Platform (NB3), Rio de Janeiro, RJ, Brazil.
- Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
- Leônidas and Maria Deane Institute, Rio de Janeiro, Amazonas, Brazil.
- Intensive Care Unit, Hospital Pró-Cardíaco, Rio de Janeiro, RJ, Brazil.
- Laboratory of Immunopharmacology, IOC/FIOCRUZ, Rio de Janeiro, RJ, Brazil.
- Faculdade de Medicina, Universidade Estácio de Sá, IDOMED, Rio de Janeiro, RJ, Brazil.
MeSH
Mortality, Longitudinal Studies, Severe Acute Respiratory Syndrome